Medeon International, Inc announced a private placement of 400,040 common stock at issue price of $1 per stock for gross proceeds of $4,000,040 on June 14, 2024. The transaction will include participation from new investor, Medeon Biodesign, Inc. The transaction has been approved at the board of directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.6 TWD | -0.98% | +11.45% | +8.47% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.47% | 144M | |
+4.13% | 213B | |
+9.10% | 188B | |
+31.39% | 157B | |
+33.07% | 113B | |
+5.25% | 64.85B | |
+22.59% | 55.17B | |
+1.34% | 49.1B | |
-5.36% | 38.83B | |
+1.91% | 35.6B |
- Stock Market
- Equities
- 6499 Stock
- News Medeon Biodesign, Inc.
- Medeon International, Inc announced that it expects to receive $4.00004 million in funding from Medeon Biodesign, Inc.